Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Journal of Cancer Survivorship : Research and Practice
|
January 18, 2025
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional study
Zsuzsanna Iyizoba-Ebozue, Emma Nicklin, Stuart Currie, et al.
Journal of Cancer Survivorship : Research and Practice
|
August 1, 2025
Neurocognitive concerns and neurocognitive impairment in long-term survivors of oropharyngeal cancer post (chemo)radiotherapy
Zsuzsanna Iyizoba-Ebozue, Robin Prestwich, Maryse Luijendijk, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 6, 2022
Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study
Carlos E Cardenas, Sanne E Blinde, Abdallah S R Mohamed, et al.
The Lancet. Oncology
|
June 27, 2024
Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations
Annette M Lim, Lachlan McDowell, Chris Hurt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 10, 2023
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)
David J Thomson, Nick J Slevin, Helen Baines, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
James M Price, Hitesh B Mistry, Guy Betts, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 2, 2026
Global dose prescription variances exemplified through oropharynx cancer: when is 70 Gray 70 Gray?
Christian Rønn Hansen, Tony Tadic, Manju Sharma, et al.
Lancet (London, England)
|
March 24, 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
David J Thomson, James M Price, Matthew Tyler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2020
Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development
David J Thomson, Sue S Yom, Hina Saeed, et al.
Clinical and Translational Radiation Oncology
|
December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
David J Thomson, Clare Cruickshank, Helen Baines, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Journal of Cancer Survivorship : Research and Practice
|
January 18, 2025
Multidimensional fatigue and its impact on work productivity, mood and quality of life in long-term survivors following definitive intensity-modulated radiotherapy for oropharyngeal cancer: A cross-sectional study
Zsuzsanna Iyizoba-Ebozue, Emma Nicklin, Stuart Currie, et al.
Journal of Cancer Survivorship : Research and Practice
|
August 1, 2025
Neurocognitive concerns and neurocognitive impairment in long-term survivors of oropharyngeal cancer post (chemo)radiotherapy
Zsuzsanna Iyizoba-Ebozue, Robin Prestwich, Maryse Luijendijk, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 6, 2022
Comprehensive Quantitative Evaluation of Variability in Magnetic Resonance-Guided Delineation of Oropharyngeal Gross Tumor Volumes and High-Risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study
Carlos E Cardenas, Sanne E Blinde, Abdallah S R Mohamed, et al.
The Lancet. Oncology
|
June 27, 2024
Assessment of endpoint definitions in curative-intent trials for mucosal head and neck squamous cell carcinomas: Head and Neck Cancer International Group consensus recommendations
Annette M Lim, Lachlan McDowell, Chris Hurt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 10, 2023
Randomized Phase 3 Trial of the Hypoxia Modifier Nimorazole Added to Radiation Therapy With Benefit Assessed in Hypoxic Head and Neck Cancers Determined Using a Gene Signature (NIMRAD)
David J Thomson, Nick J Slevin, Helen Baines, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2022
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer
James M Price, Hitesh B Mistry, Guy Betts, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 2, 2026
Global dose prescription variances exemplified through oropharynx cancer: when is 70 Gray 70 Gray?
Christian Rønn Hansen, Tony Tadic, Manju Sharma, et al.
Lancet (London, England)
|
March 24, 2026
Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial
David J Thomson, James M Price, Matthew Tyler, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2020
Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development
David J Thomson, Sue S Yom, Hina Saeed, et al.
Clinical and Translational Radiation Oncology
|
December 1, 2022
TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer
David J Thomson, Clare Cruickshank, Helen Baines, et al.
Page
of 7